20842-22-2 Usage
Description
2-Furancarboxylic acid, 4,5-dimethyl-, hydrazide is a hydrazide derivative of 2-furancarboxylic acid with the molecular formula C7H10N2O2. It is a chemical compound that exhibits antifungal and antibacterial properties, making it a potentially valuable molecule for the development of new antimicrobial agents. Its structure and properties also make it a promising candidate for use in the production of polymers and other advanced materials.
Uses
Used in Pharmaceutical Industry:
2-Furancarboxylic acid, 4,5-dimethyl-, hydrazide is used as a precursor for the synthesis of various pharmaceuticals. Its antifungal and antibacterial properties make it a potentially valuable molecule for the development of new antimicrobial agents.
Used in Agrochemical Industry:
2-Furancarboxylic acid, 4,5-dimethyl-, hydrazide is used as a precursor for the synthesis of various agrochemicals. Its antifungal and antibacterial properties make it a potentially valuable molecule for the development of new antimicrobial agents in agriculture.
Used in Polymer and Advanced Materials Production:
2-Furancarboxylic acid, 4,5-dimethyl-, hydrazide is used as a promising candidate for the production of polymers and other advanced materials due to its structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 20842-22-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,4 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20842-22:
(7*2)+(6*0)+(5*8)+(4*4)+(3*2)+(2*2)+(1*2)=82
82 % 10 = 2
So 20842-22-2 is a valid CAS Registry Number.
20842-22-2Relevant articles and documents
TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
-
, (2018/06/12)
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed.
STAT3 INHIBITOR CONTAINING QUINOLINECARBOXAMIDE DERIVATIVE AS ACTIVE INGREDIENT
-
Page/Page column 66, (2011/06/24)
The present invention provides a STAT3 inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and Rs
